Rituximab-Associated Flare of Cryoglobulinemic Vasculitis

Patients with cryoglobulinemic vasculitis (CV) can develop disease flare after rituximab administration. The objective of our study was to describe the prevalence, clinical characteristics, predisposing factors, and outcomes of patients with rituximab-associated flare of CV.We conducted a retrospective study in a tertiary referral center until March 25, 2020.Among 64 patients with CV who received rituximab therapy in our center, 14 (22%)...